Huawe Overview
- Year Founded
-
2000

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$286M
- Investors
-
2
Huawe General Information
Description
Provider of healthcare technology services intended to progress in pharmaceutical, drug discovery and medical research fields. The company's healthcare technology services also offers medical outsourcing and includes registration, clinical and supply of pharmaceuticals ingredients, enabling healthcare professionals to get advanced medicine for treatment of complex diseases.
Contact Information
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Drug Delivery
Acquirer
Primary Office
- Building C3, Jiangsu Life Science & Technology Innovation Park
- Weidi road 9, Qixia District
- Nanjing, Jiangsu
- China
+86 025 0000 0000
Huawe Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 23-Aug-2016 | $286M | 00000 | Completed | Generating Revenue | |
2. Later Stage VC | 01-Jan-2016 | Completed | Generating Revenue | |||
1. Later Stage VC | Completed | Generating Revenue |
Huawe Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Xiaoqing Zhang | Co-Founder |
Huawe Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Caihong Zheng | Huawe | Chairman | 000 0000 |
Huawe Former Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Addor Capital | Growth/Expansion | Minority | 000 0000 | 000000 0 |